List of articles with "Palatin Technologies"

Ulcerative Colitis Breakthrough

Ulcerative Colitis Breakthrough

United States Ulcerative Colitis Palatin Technologies PL8177 Cranbury
Palatin Q2 FY2025 Update

Palatin Q2 FY2025 Update

USA Palatin Technologies Cranbury tirzepatide MC4R agonist
Palatin's $4.7 Million Offering

Palatin's $4.7 Million Offering

United States Palatin Technologies Cranbury Biopharmaceutical stock offering
Obesity Trial Results

Obesity Trial Results

USA Palatin Technologies Cranbury GLP-1 tirzepatide MC4R bremelanotide
Palatin's 2025 Milestones

Palatin's 2025 Milestones

United States Palatin Technologies Cranbury tirzepatide MC4R agonist
BREAKOUT Study Success

BREAKOUT Study Success

United States Palatin Technologies Cranbury Bremelanotide Diabetic Nephropathy
Palatin Raises $3.4M

Palatin Raises $3.4M

USA Palatin Technologies Cranbury NYSE PTN Melanocortin
PL8177 Trial Update

PL8177 Trial Update

USA Ulcerative Colitis Palatin Technologies PL8177 Cranbury

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.